Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (101)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

    Drug Design, Development and Therapy, Vol. 17, pp. 155-166

  3. COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study

    International Journal of Infectious Diseases, Vol. 134, pp. 154-159

  4. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  5. HTLV European Research Network 2023: the silent pandemic of HTLV-1 infection

    AIDS Reviews

  6. HTLV infection in persons with sexually transmitted diseases in Spain

    Frontiers in Immunology, Vol. 14

  7. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

  8. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  9. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

    Autoimmunity Reviews, Vol. 22, Núm. 6

  10. Predictors of in-hospital mortality in HIV-infected patients with COVID-19

    QJM, Vol. 116, Núm. 1, pp. 57-62

  11. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  12. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  13. The slowdown of new infections by human retroviruses has reached a plateau in Spain

    Journal of Medical Virology, Vol. 95, Núm. 5

  14. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115